Loading
EM
ENvue Medical, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Glibert Christian Michael, was filed 11 Feb 2026.
Insider Decl.
25
Thresholds
n/a
Buy Volume
€640,307
7 ops. · all time
Sell Volume
€131,726
17 ops. · all time
Who traded when
BuySaleBank of America Corp /DE/16 sales
Christian Michael Glibert1 buy1 sale
Since the insiders bought
- -59.2%Entry US$34.08 · Close at T+90 US$13.92
- -81.3%Entry US$7,260.00 · Close at T+365 US$1,359.60
- +17.8%Entry US$56.80 · Close at T+365 US$66.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.37
Analyst consensus
Income statement
RevenueUS$2.6M
Gross profitUS$153k6% margin
EBITDA-US$10.8M-425% margin
Net income-US$18.2M-712.3% margin
Valuation
P/Book0.0x
Beta1.45
Balance sheet & cash
Total debtUS$1.2M
Free Cash Flow-US$9.4M
Debt / Equity4%
Profitability & ownership
ROE-59.1%
ROA-21.0%
% insiders16.4%
% institutions2.7%
Last declaration on 22 June 2026
Declarations25 total
210,000 shares@ US$0.68818.7% of flowCommon StockSEC:0002111050-26-000007:0
00Common StockSEC:0002111050-26-000005:0
240,000 shares@ US$2.67100.0% of flowCommon Stock, par value $0.001 per shareSEC:0002111050-26-000002:0
Canonical exit: 14 Apr 2026 (T+90)
100 shares@ US$3.044.8% of flowCommon StockSEC:0000070858-26-000030:4
200 shares@ US$3.069.8% of flowCommon StockSEC:0000070858-26-000030:5
500 shares@ US$3.0524.3% of flowCommon StockSEC:0000070858-26-000030:6
50 shares@ US$3.052.4% of flowCommon StockSEC:0000070858-26-000030:7
18 shares@ US$3.050.9% of flowCommon StockSEC:0000070858-26-000030:10
183 shares@ US$3.058.9% of flowCommon StockSEC:0000070858-26-000030:16
2 shares@ US$3.050.1% of flowCommon StockSEC:0000070858-26-000030:17
417 shares@ US$3.0520.3% of flowCommon StockSEC:0000070858-26-000030:19
98 shares@ US$3.054.8% of flowCommon StockSEC:0000070858-26-000030:20
82 shares@ US$3.054.0% of flowCommon StockSEC:0000070858-26-000030:21
100 shares@ US$3.064.9% of flowCommon StockSEC:0000070858-26-000030:23
100 shares@ US$3.074.9% of flowCommon StockSEC:0000070858-26-000030:25
90 shares@ US$3.054.4% of flowCommon StockSEC:0000070858-26-000030:26
10 shares@ US$3.050.5% of flowCommon StockSEC:0000070858-26-000030:1
4 shares@ US$3.050.2% of flowCommon StockSEC:0000070858-26-000030:2
100 shares@ US$3.05100.0% of flowCommon StockSEC:0000070858-26-000030:0
50,000 shares@ US$0.25100.0% of flowCommon StockSEC:0001493152-23-000609:0
Canonical exit: 5 Apr 2023 (T+90)
40,000 shares@ US$0.5957100.0% of flowCommon StockSEC:0001493152-22-017169:0
Canonical exit: 13 Sept 2022 (T+90)
25,000 shares@ US$2.000.0000% mcap66.4% of flowCommon StockSEC:0001493152-22-017164:0
Canonical exit: 18 Feb 2020 (T+90)
4,000 shares@ US$0.5739100.0% of flowCommon StockSEC:0001493152-22-016736:0
Canonical exit: 12 Sept 2022 (T+90)
2,000 shares@ US$0.69100.0% of flowCommon StockSEC:0001493152-22-015656:0
Canonical exit: 30 Aug 2022 (T+90)
10,000 shares@ US$0.788722.8% of flowCommon StockSEC:0001493152-20-019223:0
Canonical exit: 28 Dec 2020 (T+90)
25 of 25 declarations
About ENvue Medical, Inc.
ENvue Medical, Inc. has 25 filings, 19 of them in 2026, and two kinds of filers: insiders who buy and a 10% holder who sells. Bank of America Corp /DE/ (10% Owner) signs 16 filings, all sales, the largest being EUR 1,287 on February 2, 2026. The 17 sales total EUR 131,726, with a median of EUR 257. The largest by amount is Christian Michael Glibert's, EUR 126,436 on June 22, 2026.
On the purchase side, 7 trades represent EUR 640,307, with a median of EUR 11,785, or 29% of open-market trades. Christian Michael Glibert bought for EUR 550,396 on January 14, 2026; Christopher M. Fashek (Director) for EUR 45,126 on November 20, 2019 and EUR 22,788 on June 15, 2022. From June 1, 2022 to June 15, 2022, 3 insiders bought for EUR 26,282. In all, 2 purchase filings are flagged as part of a cluster.
Read moreShow less
The filings run from 2019 to 2026 and are published with a median delay of 2 days; 19 fall in the last twelve months, including 1 purchase and 17 sales. Insiders hold 16.4% of the capital of this US healthcare and pharma company.
